Human immunodeficiency virus infection unresponsive to highly active antiretroviral therapy: Denial of poor medication adherence or recalcitrant infection?

AIDS Patient Care and STDs

Volumn 16, Issue 8, 2002, Pages 355-359

  Miller, Loren G ^a   Chang, Edmond S ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL PRACTICE; DRUG RESISTANCE; DRUG RESPONSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; TREATMENT FAILURE; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HUMANS; MALE; TREATMENT REFUSAL;

EID: 0036337750     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/10872910260196378     Document Type: Article

References (26)

1. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy
2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
3. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
4. Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center
5. How well do clinicians estimate patients' adherence to combination antiretroviral therapy?
6. Predicting compliance with a regimen of digoxin therapy in family practice
7. Diagnosing potential noncompliance
8. Drug resistance. An updated, user-friendly guide to genotype interpretation
9. A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
10. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
11. Adherence to combination anti-retroviral therapy: Synthesis of the literature and clinical implications
12. P-glycoprotein and transporter MRP1 reduce HIV protease inhibitor uptake in CD4 cells: Potential for accelerated viral drug resistance?
13. Adherence to Antiretroviral Therapy
14. Coping and medication adherence in bipolar disorder
15. Characteristics of patients with schizophrenia who do not believe they are mentally ill
16. A program to reduce onset distress in unselected type I diabetic patients: Effects on psychological variables and metabolic control
17. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates
18. Culture and 'compliance' among leprosy patients in Pakistan
19. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand
20. Medication Adherence Among HIV-Infected Patients: Understanding the complex behavior of patients taking this complex therapy
21. Adherence: A matter of self-efficacy and power
22. Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine
23. Causes of macrocytosis in HIV-infected patients not treated with zidovudine. Swiss HIV Cohort Study
24. Measuring adherence to anti-retroviral medications in clinical trials
25. Primary non-compliance with prescribed medication in primary care
26. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy